|
NCCN Guidelines® Insights - Management of Immunotherapy-Related Toxicities, Version 2.2024 |
1.00 |
11/10/2024 - 12:00am to 11/10/2025 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: Chemoimmunotherapy Updates in Advanced/Metastatic Non-Small Cell Lung Cancer |
1.00 |
11/12/2024 - 12:00am to 11/12/2025 - 12:00am |
|
NCCN Tumor Boards: T-Cell Engager Therapy for Diffuse Large B-Cell Lymphoma: Bispecific Antibodies for Relapsed/Refractory Disease |
1.00 |
11/14/2024 - 12:00am to 04/27/2025 - 12:00am |
|
Archived NCCN Tumor Boards: Multidisciplinary Management of Head and Neck Cancers |
1.00 |
11/26/2024 - 12:00am to 11/26/2025 - 12:00am |
|
Archived NCCN Tumor Boards: New Approaches to Treatment of Bladder Cancer |
1.00 |
11/26/2024 - 12:00am to 11/26/2025 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: Maintenance Strategies in the Management of Acute Myeloid Leukemia |
1.00 |
11/26/2024 - 12:00am to 11/26/2025 - 12:00am |
|
Amyloidosis: Diagnosis, Treatment, and Supportive Care |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
|
Diagnosis and Management of Blastic Plasmacytoid Dendritic Cell Neoplasm |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
|
Evaluation and Treatment of Primary Central Nervous System Lymphoma |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
|
Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
|
Management of TP53 Mutated Mantle Cell Lymphoma |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
|
Chronic Myeloid Leukemia: How to Treat During Pregnancy |
0.25 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
|
The Role of JAK Inhibitors in the Management of Myelofibrosis |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
|
CAR T-Cell Therapies in Hematologic Malignancies: Challenges and Strategies |
1.00 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
|
Optimizing the Use of Bispecific Antibodies in Hematologic Malignancies |
1.00 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Facebook
Twitter
LinkedIn
Forward